N@N

Douglas Tsao Reiterated (APLS) at Strong Buy and Held Target at $82 on, Aug 7th, 2023

Douglas Tsao of HC Wainwright & Co., Reiterated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $82 on, Aug 7th, 2023.

Douglas has made no other calls on APLS in the last 4 months.

There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 4 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $60 on, Thursday, August 3rd, 2023
• Brian Cheng of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Tuesday, August 1st, 2023
• Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $53 on, Thursday, July 20th, 2023
• Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023

These are the ratings of the 6 analyists that currently disagree with Douglas

---

• Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $70 on, Tuesday, August 1st, 2023
• Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $89 on, Tuesday, August 1st, 2023
• Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $60 on, Monday, July 31st, 2023
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $80 on, Friday, July 21st, 2023
• Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $108 on, Friday, May 12th, 2023
• Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $141 on, Friday, April 14th, 2023

Contributing Sources

---